| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.89 | $53.25 (0%) | 🛒 Add to cart |
| 90 | $0.81 | $79.87 $73.34 (8%) | 🛒 Add to cart |
| 120 | $0.78 | $106.49 $93.43 (12%) | 🛒 Add to cart |
| 180 | $0.75 | $159.74 $134.62 (16%) | 🛒 Add to cart |
| 270 | $0.72 | $239.61 $194.90 (19%) | 🛒 Add to cart |
| 360 | $0.71
Best per pill | $319.48 $255.18 (20%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
trazodone
Trazodone hydrochloride is a triazolopyridine derivative that functions primarily as a serotonin antagonist and reuptake inhibitor (SARI). Initially developed in the 1960s by Angelini Research Laboratories, this compound occupies a unique pharmacological niche distinct from typical SSRIs or tricyclics. We’ve been using it off-label for insomnia for decades, but the mechanism is more nuanced than just sedation. The parent molecule gets metabolized into m-chlorophenylpiperazine (mCPP), which actually has somewhat stimulatory properties - explains why some patients get restless rather than sleepy.
desyrel
Let me walk you through what we’ve learned about Desyrel over the years - this isn’t the polished monograph you’d find in packaging, but the real clinical experience that matters at 3 AM when you’re trying to help someone through a crisis. Desyrel (trazodone hydrochloride) entered our formulary back in the early 2000s, and honestly, we were skeptical at first. Another antidepressant? We had SSRIs dominating the landscape, and here came this serotonin antagonist and reuptake inhibitor (SARI) with this unusual dual mechanism.
Prazosin: Targeted Nightmare Suppression for PTSD - Evidence-Based Review
Prazosin represents one of those fascinating cases in clinical practice where a medication developed for one purpose finds its most profound utility in an entirely different domain. Originally introduced as an antihypertensive agent, this selective alpha-1 adrenergic receptor antagonist has carved out a crucial niche in managing trauma-related conditions, particularly nightmares associated with post-traumatic stress disorder (PTSD). What began as a cardiovascular drug has transformed into a frontline intervention for one of psychiatry’s most challenging symptoms.
sinequan
Doxepin hydrochloride, marketed under the brand name Sinequan, is a tricyclic antidepressant (TCA) with a unique pharmacological profile that has maintained clinical relevance decades after its initial development. Originally approved by the FDA in 1969, its primary mechanism involves potent inhibition of histamine H1 receptors, making it one of the most sedating antidepressants available, alongside its well-characterized inhibition of serotonin and norepinephrine reuptake. What’s fascinating is how its utility has evolved – we initially used it strictly for major depressive disorder, but its profound effect on sleep architecture and pruritus (itching) has carved out significant niches in dermatology and sleep medicine that many newer medications can’t touch.
ventodep er
Ventodep ER represents one of those rare clinical tools that actually delivers on its theoretical promise. When we first started working with the extended-release melatonin formulation about three years ago, I’ll admit I was skeptical—melatonin supplements had always been so hit-or-miss in my practice. But this particular delivery system, with its dual-phase release profile, has fundamentally changed how I approach circadian rhythm disorders, especially in patients with comorbid conditions. The device itself is surprisingly simple—a small transdermal patch about the size of a postage stamp that delivers 2mg of sustained-release melatonin over 8 hours.
a ret gel
A topical retinoid formulation combining tretinoin 0.025% in a novel hydrogel delivery system designed for enhanced epidermal penetration while minimizing irritation. The gel matrix utilizes carbomer technology with ceramide encapsulation to stabilize the active ingredient and improve skin barrier compatibility. This represents a significant advancement over traditional cream-based retinoid formulations that often suffer from oxidation and inconsistent delivery. 1. Introduction: What is a ret gel? Its Role in Modern Dermatology a ret gel refers specifically to tretinoin hydrogel formulations that have revolutionized topical retinoid therapy.
Abana: Comprehensive Cardiovascular Support and Lipid Management - Evidence-Based Review
Product Description: Abana represents one of those formulations that makes you appreciate the wisdom behind traditional medicine systems. It’s not just another herbal supplement - it’s a comprehensive cardiovascular support system that’s been used in Ayurvedic practice for centuries. What struck me early in my clinical experience was how it addresses multiple aspects of cardiac health simultaneously, something our conventional approaches often struggle with. 1. Introduction: What is Abana? Its Role in Modern Medicine When patients first ask me “what is Abana used for,” I explain it’s not a single-ingredient supplement but rather a sophisticated polyherbal formulation that’s stood the test of time.
Abhigra: Comprehensive Metabolic and Inflammatory Support - Evidence-Based Review
Before we dive into the formal monograph, let me give you the real story behind Abhigra. We initially developed it as an adjunct therapy for patients with persistent subclinical inflammation who weren’t responding adequately to conventional approaches. The name comes from Sanskrit - “abhi” meaning “towards” and “graha” meaning “to seize or grasp” - reflecting our intention to help the body better grasp homeostasis. What’s interesting is that our initial hypothesis was completely wrong.
abilify
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in the atypical antipsychotic class with its unique pharmacodynamic profile. Unlike earlier antipsychotics that primarily functioned as dopamine antagonists, aripiprazole’s mechanism as a partial dopamine agonist created what we initially called “dopamine system stabilization” - a concept that seemed almost paradoxical when first introduced. The development team at Otsuka Pharmaceutical faced considerable skepticism about whether a compound could simultaneously act as both agonist and antagonist depending on the dopaminergic environment.